Trial 6G-13-1


A Prospective, Non-Randomized, Concurrent Control, Open Label, Post-Approval Study Of NovoTTF-100A In Recurrent GBM Patients

Type: Treatment
Phase: Phase IV
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic, Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Thomas Chen, M.D.
Other Trial Staff:  Sandy Leong, R.N., Anush Arakelyan, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.